Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally
Congenica today announced it has renamed its software platform Congenica® and expanded its capabilities to include CNV calling for exome and gene panel sequencing.
Enabling genomic medicine
Our brand identity reflects the unique work we do and our commitment to empowering healthcare professionals to make important clinical decisions.
Should you get your genome sequenced?
If you could afford it, would you get your genome sequenced? We live in exciting times, it will not be long before we are all comparing our genome data.
Congenica named in UK life sciences – Catalysing investment and growth report
Congenica named in UK life sciences – Catalysing investment and growth report
Improving Diagnosis for Patients with Rare Genetic Disease
Improving Diagnosis for Patients with Rare Genetic Disease
BGI Genomics Launch Clinical Research Whole Exome Sequencing and Interpretation Service Using Congenica Clinical Decision Support Platform
BGI Genomics Launch Clinical Research Whole Exome Sequencing and Interpretation Service Using Congenica Clinical Decision Support Platform
Congenica supports fast, meaningful results achieved in important project
Congenica supports fast, meaningful results achieved in important project
Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round
Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round
Congenica co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society
Congenica co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society
Congenica Announces On-Premise Deployment Option for its Genomic Analysis Platform
Congenica Announces On-Premise Deployment Option for its Sapientia Platform
